Research ArticleArticle
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease — Scleroderma Clinical Trials Consortium
Zsuzsanna H. McMahan, Tracy Frech, Veronica Berrocal, David Lim, Cosimo Bruni, Marco Matucci-Cerinic, Vanessa Smith, Karin Melsens, Susanna Proudman, Jinyu Zhang, Fabian Mendoza, Melanie Woods and Dinesh Khanna
The Journal of Rheumatology November 2018, jrheum.180004; DOI: https://doi.org/10.3899/jrheum.180004
Zsuzsanna H. McMahan
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Tracy Frech
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Veronica Berrocal
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
David Lim
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Cosimo Bruni
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Marco Matucci-Cerinic
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Vanessa Smith
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Karin Melsens
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Susanna Proudman
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Jinyu Zhang
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Fabian Mendoza
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Melanie Woods
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Dinesh Khanna
From the Division of Rheumatology, Johns Hopkins University School of Medicine, Baltimore, Maryland; Division of Rheumatology, University of Utah, Salt Lake City, Utah; Department of Biostatistics, and Division of Rheumatology, University of Michigan, Ann Arbor Michigan, USA; Division of Rheumatology, University of Florence, Florence, Italy; Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University, Ghent, Belgium; Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide, Adelaide, Australia; Department of Medicine, and Division of Rheumatology, Thomas Jefferson University Hospital, Philadelphia, Pennsylvania, USA. This research was supported by the Scleroderma Clinical Trials Consortium. Z.H. McMahan, Assistant Professor, MD, MHS, Division of Rheumatology, Johns Hopkins University School of Medicine; T. Frech, Associate Professor, MD, MS, Division of Rheumatology, University of Utah; V. Berrocal, Associate Professor, PhD, Department of Biostatistics, University of Michigan; D. Lim, PhD student, BS, Department of Biostatistics, University of Michigan; C. Bruni, Clinical Research Fellow, MD, Division of Rheumatology, University of Florence; M. Matucci-Cerinic, Professor, MD, PhD, Division of Rheumatology, University of Florence; V. Smith, Associate Professor, MD, PhD, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; K. Melsens, MSc, PhD student, Division of Rheumatology, Ghent University Hospital, Faculty of Internal Medicine, Ghent University; S. Proudman, Associate Professor, MBBS, Rheumatology Unit, Royal Adelaide Hospital, Discipline of Medicine, University of Adelaide; J. Zhang, Gastroenterology Fellow, MD, Department of Medicine, Thomas Jefferson University Hospital; F. Mendoza, Assistant Professor, MD, Division of Rheumatology, Thomas Jefferson University Hospital; M. Woods, Department of Biostatistics, University of Michigan; D. Khanna, Professor, MD, MS, Division of Rheumatology, University of Michigan. Dr. Z.H. McMahan and Dr. T. Frech contributed equally to this work. Address correspondence to Dr. D. Khanna, Professor of Medicine, Division of Rheumatology, Department of Internal Medicine, University of Michigan, 24 Frank Lloyd Wright Dr., Ann Arbor, Michigan 48105, USA. E-mail: khannad@med.umich.edu. Accepted for publication August 8, 2018.
Published eLetters
eLetters are comments published online only and are not peer-reviewed. Publication of eLetter submissions is not guaranteed, and all submissions are reviewed and edited at the discretion of The Journal's staff.
If you wish to publish Letters to the Editor or Correspondence, please submit through our online submission system ScholarOne Manuscripts.
Jump to comment:
No eLetters have been published for this article.
In this issue
The Journal of Rheumatology
Vol. 51, Issue 4
1 Apr 2024
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease — Scleroderma Clinical Trials Consortium
Zsuzsanna H. McMahan, Tracy Frech, Veronica Berrocal, David Lim, Cosimo Bruni, Marco Matucci-Cerinic, Vanessa Smith, Karin Melsens, Susanna Proudman, Jinyu Zhang, Fabian Mendoza, Melanie Woods, Dinesh Khanna
The Journal of Rheumatology Nov 2018, jrheum.180004; DOI: 10.3899/jrheum.180004
Longitudinal Assessment of Patient-reported Outcome Measures in Systemic Sclerosis Patients with Gastroesophageal Reflux Disease — Scleroderma Clinical Trials Consortium
Zsuzsanna H. McMahan, Tracy Frech, Veronica Berrocal, David Lim, Cosimo Bruni, Marco Matucci-Cerinic, Vanessa Smith, Karin Melsens, Susanna Proudman, Jinyu Zhang, Fabian Mendoza, Melanie Woods, Dinesh Khanna
The Journal of Rheumatology Nov 2018, jrheum.180004; DOI: 10.3899/jrheum.180004